Zolpidem withdrawal delirium, seizure, and acute psychosis: Case reports and literature review

References

• Adamowicz, P., & Kala, M. (2005). Date-rape drugs scene in Poland. Przegl Lek, 62, 572–575.
   Google Scholar
• Aragona, M. (2000). Abuse, dependence, and epileptic seizures after zolpidem withdrawal: Review and case report. Clinical Neuropharmacology, 23(5), 281–283.
   PubMed Web of Science ®Google Scholar
• Arbilla, S., Allen, J., Wick, A., & Langer, S. Z. (1986). High affinity [3H]zolpidem binding in the rat brain: An imidazopyridine with agonist properties at central benzodiazepine receptors. European Journal of Pharmacology, 130, 257–263.
   Google Scholar
• Arbilla, S., Depoortere, H., George, P., & Langer, S. Z. (1985). Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats. Naunyn Schmiedebergs Archives of Pharmacology, 330, 248–251.
   PubMed Web of Science ®Google Scholar
• Balíková, M. (2005). Hair analysis for drugs of abuse. Plausibility of interpretation. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia Republication, 149, 199–207.
   PubMedGoogle Scholar
• Barrero-Hernandez, F. J., Ruiz-Veguilla, M., Lopez-Lopez, M. I., Casado-Torres, A. (2002). Epileptic seizures as a sign of abstinence from chronic consumption of zolpidem. Reviews in Neurology, 34, 253–256.
   PubMed Web of Science ®Google Scholar
• Bishnoi, M., Chopra, K., & Kulkarni, S. K. (2007). Possible anti-oxidant and neuroprotective mechanism of zolpidem in attenuating typical anti-psychotic induced orofacial dyskinesia: a biochemical and neurochemical study. Progress in Neuropsychopharmacology and Biological Psychiatry, 30, 1130–1138.
   Google Scholar
• Boettger, S., & Breitbart, W. (2005). Atypical antipsychotics in the management of delirium: A review of the empirical literature. Palliative Support Care, 3, 227–237.
   PubMedGoogle Scholar
• Boulanger-Rostowsky, L., Fayet, H., Benmoussa, N., & Ferrandi, J. (2004). Dependence on zolpidem: A report of two cases. Encephale, 30, 153–155.
   Google Scholar
• Cubala, W. J., & Landowski, J. (2006). Seizure following sudden zolpidem withdrawal. Progress in Neuropsychopharmacology and Biological Psychiatry, 2, 539–540.
   Google Scholar
• Depoortere, H., Zivkovic, B., Lloyd, K. G., Sanger, D. J., Perrault, G., Langer, S. Z., & Bartholini, G. (1986). Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. Journal of Pharmacology and Experimental Therapy, 237, 649–658.
   PubMed Web of Science ®Google Scholar
• Druid, H., Holmgren, P., & Ahlner, J. (2001). Flunitrazepam: an evaluation of use, abuse and toxicity. Forensic Science International, 122(2–3), 136–141.
   PubMed Web of Science ®Google Scholar
• Goa, K. L., & Heel, R. C. (1986). Zopiclone. A review of its pharmacodynamic and pharmakinetic properties and therapeutic efficacy as a hypnotic. Drugs, 32, 48–65.
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., Sannerud, C. A., Ator, N. A., & Brady, J. V. (1992). Zolpidem behavioral pharmacology in baboons: Self-injection, discrimination, tolerance and withdrawal. Journal of Pharmacology and Experimental Therapy, 260, 1199–1208.
   PubMedGoogle Scholar
• Jansen, K. L., & Theron, L. (2006). Ecstasy (MDMA), methamphetamine, and date rape (drug-facilitated sexual assault): A consideration of the issues. Journal of Psychoactive Drugs, 38, 1–12.
   PubMed Web of Science ®Google Scholar
• Lader, M. (1992). Rebound insomnia and newer hypnotics. Psychopharmacology, 108, 248–255.
   PubMed Web of Science ®Google Scholar
• Langer, S. Z., & Arbilla, S. (1988a). Imidazopyridines as a tool for the characterization of benzodiazepine receptors: A proposal for a pharmacological classification as omega receptor subtypes. Pharmacological and Biochemical Behaviour, 29, 763–766.
   PubMed Web of Science ®Google Scholar
• Langer, S. Z., & Arbilla, S. (1988b). Limitations of the benzodiazepine receptor nomenclature: A proposal for a pharmacological classification as omega receptor subtypes. Fundamental Clinical Pharmacology, 2(3), 159–170.
   Google Scholar
• Langtry, H. D., & Benfield, P. (1990). Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs, 40, 291–313.
   PubMed Web of Science ®Google Scholar
• Leppik, I. E., Roth-Schecter, G. B., & Gray, G. W. (1997). Double-blind, placebo-controlled comparison of zolpidem, triazolam, and tremazepam in elderly patients with insomnia. Drug and Development Research, 40, 230–238.
   Web of Science ®Google Scholar
• Liappas, I. A., Malitas, P. N., Dimopoulos, N. P., Gitsa, O. E., Liappas, A. I., Nikolaou, C. K., & Christodoulou, G. N. (2003). Zolpidem dependence case series: Possible neurobiological mechanisms and clinical management. Journal of Psychopharmacology, 17, 131–135.
   PubMed Web of Science ®Google Scholar
• Markowitz, J. S., & Brewerton, T. D. (1996). Zolpidem-induced psychosis. Annals of Clinical Psychiatry, 8(2), 89–91.
   Google Scholar
• Mariani, J. J., & Levin, F. R. (2007). Quetiapine treatment of zolpidem dependence. American Journal of Addiction, 16, 426.
   PubMed Web of Science ®Google Scholar
• McGeown, P., & Helliwell, D. (2006). Treating BZD dependency. Available at: http://216.55.99.51/clinical/drug&alcohol/drug&alcoho3585.html Accessed 3 December 2008.
   Google Scholar
• National Institute for Clinical Excellence (2006). Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia. Available at: http://www.nice.org.uk
   Google Scholar
• Perrault, G., Morel, E., Sanger, D. J., & Zivkovic, B. (1990). Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. European Journal of Pharmacology, 187, 487–494.
   PubMedGoogle Scholar
• Pitner, J. K., Gardner, M., Neville, M., & Mintzer, J. (1997). Zolpidem-induced psychosis in an older woman. Journal of the American Geriatric Society, 45, 533–534.
   PubMed Web of Science ®Google Scholar
• Rappa, L. R., Larose-Pierre, M., Payne, D. R., Eraikhuemen, N. E., Lanes, D. M., & Kearson, M. L. (2004). Detoxification from high-dose zolpidem using diazepam. Annals of Pharmacotherapy, 38, 590–594.
   PubMed Web of Science ®Google Scholar
• Sanger, D. J., Benavides, J., Perrault, G., Morel, E., Cohen, C., Joly, D., & Zivkovic, B. (1994). Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: Evidence for the functional significance of receptor subtypes. Neuroscience and Biobehaviour Review, 18, 355–372.
   PubMed Web of Science ®Google Scholar
• Sanger, D. J., Morel, E., & Perrault, G. (1996). Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem. European Journal of Pharmacology, 313, 35–42.
   PubMed Web of Science ®Google Scholar
• Sanger, D. J., & Zivkovic, B. (1988). Further behavioural evidence for the selective sedative action of zolpidem. Neuropharmacology, 27, 1125–1130.
   PubMed Web of Science ®Google Scholar
• Schwartz, T. L., & Masand, P. S. (2002). The role of atypical antipsychotics in the treatment of delirium. Psychosomatics, 43(3), 171–174.
   Google Scholar
• Schwartz, R. H., Milteer, R., & LeBeau, M. A. (2000). Drug-facilitated sexual assault (date rape). Southern Medical Journal, 93, 558–561.
   PubMed Web of Science ®Google Scholar
• Sethi, P. K., & Khandelwal, D. C. (2005). Zolpidem at supratherapeutic doses can cause drug abuse, dependence and withdrawal seizure. Journal of the Association of Physicians India, 53, 139–140.
   PubMedGoogle Scholar
• Sharan, P., Bharadwaj, R., Grover, S., Padhy, S. K., Kumar, V., & Singh, J. (2007). Dependence syndrome and intoxication delirium associated with zolpidem. National Medical Journal of India, 20(4), 180–181.
   Google Scholar
• Treiman, D. M. (2001). GABAergic mechanisms in epilepsy. Epilepsia, 42(Suppl. 3), 8–12.
   PubMedGoogle Scholar
• Tripodianakis, J., Potagas, C., Papageorgiou, P., Lazaridou, M., & Matikas, N. (2003). Zolpidem-related epileptic seizures: a case report. European Psychiatry, 18(3), 140–141.
   PubMed Web of Science ®Google Scholar
• Van Puijenbroek, E. P., Egberts, A. C., & Krom, H. J. (1996). Visual hallucinations and amnesia associated with the use of zolpidem. International Journal of Clinical Pharmacology and Therapy, 34(7), 318.
   Google Scholar
• Woods, J. H., Katz, J. L., & Winger, G. (1992). Benzodiazepines: Use, abuse and consequences. Pharmacological Review, 44, 151–347.
   PubMed Web of Science ®Google Scholar